Ethical/Legal Considerations: A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and must, if accepted, not be published elsewhere in similar form, in any language. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the Journal's editorial office.
Ethics and malpractice statements of the Journal of Fasting and Health are based on COPE’s Best Practice Guidelines for Journal Editors and pertain to all parties involved in the publishing: the editor, the peer reviewer and the author.
Patient anonymity and informed consent It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. The protocol of the study must be approved by the Institutional Review Board (IRB) or the equivalent (e.g., Research Ethics Board) where the study is conducted. Each author warrants that he or she has obtained, prior to submission, written releases from patients whose names or photographs are submitted as part of the manuscript.
Conflicts of Interest: Authors should disclose, at the time of submission, information on financial conflicts of interest or other interests that may influence the manuscript. Authors should declare sources of funding for the work undertaken.
Publications are made subject to copyright for the protection of the authors and the publisher. Accepted manuscripts become the permanent property of the JFH and may not be reproduced, in whole or in part, without the written permission of the Editor.
All contributions selected for peer review are sent to at least two, independent reviewers, designated by the editors. JFH's editors may seek advice about submitted papers from technical and statistical referees on any aspect of a paper that raises concerns. These may include ethical issues or issues of data or materials access. As in all publishing decisions, the ultimate decision whether to publish is the responsibility of the Editor of the journal concerned.
Decisions: The single most important criterion for acceptance is the originality of the work. However, a decision to accept is not solely based on the scientific validity of the paper's content. Other factors affecting decisions include the extent and importance of new information in the paper compared with papers previously published or under consideration; the Journal's need to represent a wide range of topics and the overall suitability for this journal. Decision letters usually, but not always convey all factors considered for a particular decision. Occasionally the comments to the author may appear to be inconsistent with the editorial decision, which takes into consideration confidential reviewers' comments to the Editor as well as the above factors.
Clinical Trials: Manuscripts based on a prospective clinical trial should document the registration of the clinical trial. If the trial is not registered, the authors should provide reasons for this omission. The final decision of the relevance of trial registration to any manuscript will be made by the editor.
Online manuscript submission:
Manuscripts should only be electronically submitted through online submission system in http://jfh.mums.ac.ir/ .A manuscript number will be mailed to the corresponding author shortly after submission.
Preparation of Manuscript Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Articles submitted to the journal must be written with a solid basis of English language. Manuscripts should be typewritten, using DOUBLE SPACING and 1-inch (2.5 cm) margins. Pages should be numbered consecutively starting with the title page.
Manuscripts should be kept to a minimum length and should be subdivided into labeled sections:
Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement, References, Figure legends, Tables.
Cover Letter: The cover letter should make it clear that the final manuscript has been seen and approved by all authors and that they have taken due care to ensure the integrity of their work and their personal scientific reputation. Any potential conflicts of interest should be declared, in addition to any information on prior or duplicate publication.
Title Page: This should include:
1) Title of paper (use no abbreviations, limit: 120 characters with spaces),
2) Running head of fewer than 55 characters with spaces,
3) Full names of all authors with highest academic degree(s),
4) Affiliations of all authors,
5) A word count for the entire manuscript (including figures and tables), and the number of figures and tables,
6) The complete mailing address (including telephone, fax, and e-mail address of the corresponding author for e-mailing proofs and reprint requests).
Acknowledgments: Acknowledge only persons who have made substantive contributions to the study. Authors are responsible for obtaining permission of everyone acknowledged by name. If the name of the individual performing statistical consultation is not included with authors, acknowledgment must include name and degree of statistician. Acknowledge all funding and material support, both direct and indirect for the work represented by the manuscript; include commercial, institutional, and other forms of support.
Abstract: Abstracts should be no more than 250 words, in accordance with Medline limitations and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. Complete sentences, active verbs, and the third person should be used, and the abstract should be written in the past tense. Standard nomenclature should be used and abbreviations should be avoided. No literature should be cited. The structured abstract for an original investigation should be organized as follows: Introduction: The abstract should begin with a clear statement of the precise objective or question addressed in the paper. If a hypothesis was tested, it should be stated. Materials and Methods: The basic design of the study and its duration should be described. The methods used should be stated, the statistical data/methods provided and referenced. Results: The main results of the study should be given in narrative form. Measurements or other information that may require explanation should be defined. Levels of statistical significance should be indicated, including other factors crucial to the outcome of the study. Conclusion(s): State only conclusions that are directly supported by the evidence and the implications of the findings. Key Words: 3 to 6 descriptive keywords chosen from the Medical Subject Headings (MeSH) list, immediately after the abstract. Key Words should be selected from the body of the text and not duplicate title words and should be sorted alphabetically
Structure of Text:
Introduction: Context of study.
Materials and Methods: Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference; only relevant modification should be described.
Results: These should be clear and concise and not duplicate data in Tables.
Discussion: This should be relevant to the results and placed in context of the current literature.
Conclusion: (no longer than 50 words) summarize your findings.
References: References are numbered sequentially in the order in which they first appear in the text in square brackets. All references cited in the text should be listed at the end of the manuscript on a separate page. All items in the reference list should be cited in the text and conversely, all references cited in the text must be presented in the list. The Journal has adopted the Vancouver style, citing the first six authors and then adding et al. and uses page ranges. References to periodicals should be as follows: name and initials of authors, title of paper, abbreviated journal title (conforming to those used in Index Medicus), year, and first and last pages of the article. Book references should be as follows: author, initials, title of book, title of series and volume number (if applicable), publisher and city, and year. Multi-author books or to proceedings printed in book form should be similar to those for monograph books.
Article: 1. Norouzy A, Hashemi P, Amiri A, Salehi M, Deldar K, Fakhar Y, et al. Adult malnutrition screening, prevalence in four Iranian hospitals: Cross-sectional study. Med j nut met 2012;5(1):45-48.
Article in Book: 2. Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.
Book: 3. Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
Editor as an author: 4. Martin JB, Kasper DL, et al, editors. Harrison’s principles of internal medicine. 14th ed. New York: McGraw Hill; 1998.
Institution as an author: 5. Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992.
Software: 6. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994
Online journals: 7. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990
Database: 8. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996
World Wide Web: 9. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997
The authors are responsible for the accuracy, relevance, and completeness of each reference. For references to articles in press, supply the name of the journal. References to unpublished material, including written (not verbal) personal communications, should be included parenthetically in the text with investigators' names and initials.
Figures: Legends to Figures: Legends must be submitted for all figures. Figure legends should be brief and specific and should not duplicate the body of the text. Each illustration must have a title and an explanatory legend. The title should be part of the legend and not be reproduced on the figure itself. The legends should be placed on a separate page at the end of the manuscript after references and begin with the number of the illustration they refer to. All symbols and abbreviations used in the figure including statistical information must be explained. Use scale markers in the image for electron micrographs, and indicate the type of stain used. Figures and other graphic material: May be formatted in any common file format, such as TIFF, GIF, JPG, or BMP as long as quality and resolution are borne in mind. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs, radiographs, CT scans, and so on, and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted on a 3½-inch high-density disk, a CD-ROM, or an Iomega Zip disk.
Tables: Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
*For short communication, follow the instructions for original articles, except that the total word number of the main text (excluding references, tables and figure legends) is limited to 2000 with no more than 2 figures and/or tables and no more than 15 references. An abstract, not exceeding 150 words, should be presented at the beginning of the article.
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages will be sent to the corresponding author by e-mail. Those authors without an e-mail address will receive traditional page proofs. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed or emailed within 24 to 48 hours of receipt.